$EQC
Equity Commonwealth Stock $eqc

$eqc Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000080364921000037 Filed on May 05, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$14.85M	$18.82M
YoY Change	-21.09%	-54.92%
Cost Of Revenue	$6.600M	$8.800M
YoY Change	-25.0%	-44.3%
Gross Profit	$8.200M	$10.10M
YoY Change	-18.81%	-61.15%
Gross Profit Margin	55.22%	53.67%
Selling, General & Admin	$15.70M	$10.60M
YoY Change	48.11%	-12.4%
% of Gross Profit	191.46%	104.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.351M	$5.114M
YoY Change	-14.92%	-40.43%
% of Gross Profit	53.06%	50.63%
Operating Expenses	$20.10M	$15.70M
YoY Change	28.03%	-0.51%
Operating Profit	-$11.90M	-$5.600M
YoY Change	112.5%	-154.79%
Interest Expense	$0.00	$309.0K
YoY Change	-100.0%	-92.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$10.01M	$425.5M
YoY Change	-102.35%	100.83%
Income Tax	$31.00K	$40.00K
% Of Pretax Income		0.01%
Net Earnings	-$10.02M	$424.8M
YoY Change	-102.36%	101.77%
Net Earnings / Revenue	-67.46%	2256.96%
Basic Earnings Per Share
Diluted Earnings Per Share	-$81.97K	$3.355M
COMMON SHARES
Basic Shares Outstanding	122.0M shares	122.1M shares
Diluted Shares Outstanding	122.0M shares	126.6M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.971B	$3.348B
YoY Change	-11.27%	9.08%
Cash & Equivalents	$3.000B	$3.348B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$14.60M	$15.00M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.986B	$3.363B
YoY Change	-11.23%	8.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$258.1M	$259.1M
YoY Change	-0.39%	-54.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$59.10M
YoY Change		3183.33%
Total Long-Term Assets	$275.0M	$340.8M
YoY Change	-19.3%	-44.43%
TOTAL ASSETS
Total Short-Term Assets	$2.986B	$3.363B
Total Long-Term Assets	$275.0M	$340.8M
Total Assets	$3.261B	$3.704B
YoY Change	-11.97%	-0.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.00M	$26.00M
YoY Change	-19.23%	-38.53%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.10M	$31.80M
YoY Change	-17.92%	-24.82%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$25.50M
YoY Change	-100.0%	-90.73%
Other Long-Term Liabilities	$3.000M	$2.200M
YoY Change	36.36%	-56.86%
Total Long-Term Liabilities	$3.000M	$27.70M
YoY Change	-89.17%	-90.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.10M	$31.80M
Total Long-Term Liabilities	$3.000M	$27.70M
Total Liabilities	$29.06M	$59.44M
YoY Change	-51.12%	-81.56%
SHAREHOLDERS EQUITY
Retained Earnings	$3.805B	$3.788B
YoY Change	0.44%	22.94%
Common Stock	$4.296B	$4.286B
YoY Change	0.23%	-0.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.225B	$3.638B
YoY Change
Total Liabilities & Shareholders Equity	$3.261B	$3.704B
YoY Change	-11.97%	-0.27%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$10.02M	$424.8M
YoY Change	-102.36%	101.77%
Depreciation, Depletion And Amortization	$4.351M	$5.114M
YoY Change	-14.92%	-40.43%
Cash From Operating Activities	$1.548M	$11.78M
YoY Change	-86.86%	-7.77%
INVESTING ACTIVITIES
Capital Expenditures	-$3.600M	-$1.500M
YoY Change	140.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$572.6M
YoY Change	-100.0%	-13.63%
Cash From Investing Activities	-$3.607M	$571.1M
YoY Change	-100.63%	-13.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$6.093M	$26.88M
YoY Change	-77.33%	403.2%
Debt Paid & Issued, Net	$0.00	$148.0K
YoY Change	-100.0%	3.5%
Cash From Financing Activities	-$14.11M	-$31.96M
YoY Change	-55.84%	269.81%
NET CHANGE
Cash From Operating Activities	$1.548M	$11.78M
Cash From Investing Activities	-$3.607M	$571.1M
Cash From Financing Activities	-$14.11M	-$31.96M
Net Change In Cash	-$16.17M	$550.9M
YoY Change	-102.94%	-17.43%
FREE CASH FLOW
Cash From Operating Activities	$1.548M	$11.78M
Capital Expenditures	-$3.600M	-$1.500M
Free Cash Flow	$5.148M	$13.28M
YoY Change	-61.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000803649
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	1-9317
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	EQUITY COMMONWEALTH
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-6558834
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Two North Riverside Plaza, Suite 2100
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60606
CY2021Q1	dei	City Area Code CityAreaCode	(312)
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	646-2800
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	121921850	shares
CY2021Q1	us-gaap	Land Land	44060000	USD
CY2020Q4	us-gaap	Land Land	44060000	USD
CY2021Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	361107000	USD
CY2020Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	357650000	USD
CY2021Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	405167000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	401710000	USD
CY2021Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	147034000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	143319000	USD
CY2021Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	258133000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	258391000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2971052000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2987225000	USD
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	14629000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	14702000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	16862000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	17353000	USD
CY2021Q1	us-gaap	Assets Assets	3260676000	USD
CY2020Q4	us-gaap	Assets Assets	3277671000	USD
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	21007000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	20588000	USD
CY2021Q1	us-gaap	Advance Rent AdvanceRent	2979000	USD
CY2020Q4	us-gaap	Advance Rent AdvanceRent	2928000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5072000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10991000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	29058000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	34507000	USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0650
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4915196	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4915196	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4915196	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4915196	shares
CY2021Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	122880000	USD
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	122880000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	119263000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	119263000	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	121916875	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	121916875	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	121522555	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	121522555	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	1219000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1215000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4295226000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4294632000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3804930000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3814948000	USD
CY2021Q1	eqc	Cumulative Common Stock Distributions CumulativeCommonStockDistributions	4283753000	USD
CY2020Q4	eqc	Cumulative Common Stock Distributions CumulativeCommonStockDistributions	4283668000	USD
CY2021Q1	eqc	Cumulative Preferred Stock Distributions CumulativePreferredStockDistributions	711709000	USD
CY2020Q4	eqc	Cumulative Preferred Stock Distributions CumulativePreferredStockDistributions	709712000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3225176000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3236678000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	6442000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	6486000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3231618000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3243164000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3260676000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3277671000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	14169000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	17143000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	682000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1677000	USD
CY2021Q1	us-gaap	Revenues Revenues	14851000	USD
CY2020Q1	us-gaap	Revenues Revenues	18820000	USD
CY2021Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6621000	USD
CY2020Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8761000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4351000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5114000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15729000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10604000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	26701000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	24479000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1843000	USD
CY2020Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	11895000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-56000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	0	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	309000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	419620000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10007000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	425547000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-10038000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	425507000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-20000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	748000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-10018000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	424759000	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1997000	USD
CY2020Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1997000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12015000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	422762000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122002000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122148000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122002000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126605000	shares
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.46
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.46
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.35
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-10038000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	425507000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-10038000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	425507000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-20000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	748000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10018000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	424759000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3243164000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-10038000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6093000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6687000	USD
CY2021Q1	us-gaap	Dividends Dividends	2102000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3231618000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3245872000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	425507000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	20869000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6012000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3303000	USD
CY2020Q1	us-gaap	Dividends Dividends	3187000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3644614000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-10038000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	425507000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	3769000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	4382000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-56000	USD
CY2021Q1	us-gaap	Straight Line Rent StraightLineRent	307000	USD
CY2020Q1	us-gaap	Straight Line Rent StraightLineRent	-198000	USD
CY2021Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	582000	USD
CY2020Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	732000	USD
CY2021Q1	eqc	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	0	USD
CY2020Q1	eqc	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	189000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6687000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3303000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	419620000	USD
CY2021Q1	eqc	Increase Decrease In Rents Receivable And Other Assets IncreaseDecreaseInRentsReceivableAndOtherAssets	-269000	USD
CY2020Q1	eqc	Increase Decrease In Rents Receivable And Other Assets IncreaseDecreaseInRentsReceivableAndOtherAssets	733000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	535000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1128000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	51000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-996000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1548000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11778000	USD
CY2021Q1	eqc	Cash Paid For Real Estate Improvements CashPaidForRealEstateImprovements	3607000	USD
CY2020Q1	eqc	Cash Paid For Real Estate Improvements CashPaidForRealEstateImprovements	1540000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	572599000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3607000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	571059000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6093000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	26881000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	148000	USD
CY2021Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	6024000	USD
CY2020Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	1936000	USD
CY2021Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1997000	USD
CY2020Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1997000	USD
CY2021Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	0	USD
CY2020Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	997000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14114000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31959000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16173000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	550878000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2987225000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2800645000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2971052000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3351523000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	366000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-12000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2045000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	840000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1071000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5072000	USD
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5791000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2971052000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3348349000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3174000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2971052000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3351523000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3000000000.0	USD
CY2021Q1	us-gaap	Real Estate Improvements RealEstateImprovements	3500000	USD
CY2020Q1	us-gaap	Real Estate Improvements RealEstateImprovements	1200000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	9257000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	11770000	USD
CY2021Q1	us-gaap	Variable Lease Income VariableLeaseIncome	4912000	USD
CY2020Q1	us-gaap	Variable Lease Income VariableLeaseIncome	5373000	USD
CY2021Q1	us-gaap	Lease Income LeaseIncome	14169000	USD
CY2020Q1	us-gaap	Lease Income LeaseIncome	17143000	USD
CY2021Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	6000000.0	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	0.40625
CY2021Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	0.40625
CY2021Q1	eqc	Common Stock Conversion Term CommonStockConversionTerm	P6M
CY2021Q1	eqc	Common Stock Basis For Conversion CommonStockBasisForConversion	1
CY2021Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31000	USD
CY2020Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	40000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	3400000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	25000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1548936	shares
CY2021Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	0	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-10038000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	425507000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-20000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	748000	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1997000	USD
CY2020Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1997000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12015000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	422762000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-10038000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	425507000	USD
CY2021Q1	eqc	Net Income Loss Attributable To Noncontrolling Interest Diluted NetIncomeLossAttributableToNoncontrollingInterestDiluted	-20000	USD
CY2020Q1	eqc	Net Income Loss Attributable To Noncontrolling Interest Diluted NetIncomeLossAttributableToNoncontrollingInterestDiluted	748000	USD
CY2021Q1	us-gaap	Distributed Earnings DistributedEarnings	1997000	USD
CY2020Q1	us-gaap	Distributed Earnings DistributedEarnings	0	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12015000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	424759000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122002000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122148000	shares
CY2021Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0650
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	2857000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122002000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126605000	shares
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.46
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.46
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.35
CY2021Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0650
CY2021Q1	eqc	Weighted Average Number Of Shares Restricted Stock Units Unvested WeightedAverageNumberOfSharesRestrictedStockUnitsUnvested	236000	shares
CY2020Q1	eqc	Weighted Average Number Of Shares Restricted Stock Units Unvested WeightedAverageNumberOfSharesRestrictedStockUnitsUnvested	177000	shares
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment

Files In Submission

Name	View Source	Status
0000803649-21-000037-index-headers.html	Edgar Link	pending
0000803649-21-000037-index.html	Edgar Link	pending
0000803649-21-000037.txt	Edgar Link	pending
0000803649-21-000037-xbrl.zip	Edgar Link	pending
eqc-20210331.htm	Edgar Link	pending
eqc-20210331.xsd	Edgar Link	pending
eqc-20210331_cal.xml	Edgar Link	unprocessable
eqc-20210331_def.xml	Edgar Link	unprocessable
eqc-20210331_htm.xml	Edgar Link	completed
eqc-20210331_lab.xml	Edgar Link	unprocessable
eqc-20210331_pre.xml	Edgar Link	unprocessable
eqc33121exhibit101.htm	Edgar Link	pending
eqc33121exhibit311.htm	Edgar Link	pending
eqc33121exhibit312.htm	Edgar Link	pending
eqc33121exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EQC
Equity Commonwealth Stock $eqc

2021 Q1 Form 10-Q Financial Statement

#000080364921000037 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EQC Equity Commonwealth Stock $eqc

2021 Q1 Form 10-Q Financial Statement

#000080364921000037 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EQC
Equity Commonwealth Stock $eqc